{"changeSha256":"4db104f9cdf84d28adaac27ae69933686eb4668cef9cd032d88e25425e0d91c6","changedAt":"2026-07-27","changedFields":[{"after":"A GIP and GLP-1 receptor agonist. This profile cites a Zepbound label and an FDA notice.","before":"A GIP and GLP-1 receptor agonist represented by an exact current Zepbound label record and an FDA notice.","field":"Profile summary"}],"currentVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/tirzepatide/versions/2/","version":2},"id":"profile:tirzepatide:v2","interpretationBoundary":"This event describes a PeptideScanner public-version change. It does not by itself establish that the cited source changed, that a scientific conclusion changed, or that source monitoring is continuous.","kind":"profile-updated","notice":"We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change.","peptideSlugs":["tirzepatide"],"previousChangeEvent":null,"previousVersion":{"canonicalUrl":"https://peptidescanner.com/peptides/tirzepatide/versions/1/","version":1},"schemaVersion":"peptidescanner-public-correction-lineage-event/v1","sourceRecords":[{"id":"dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38","name":"DailyMed · U.S. National Library of Medicine","sourceClass":"A","title":"ZEPBOUND (tirzepatide) injection · SPL version 38 · published 2026-05-06","url":"https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=487cd7e7-434c-4925-99fa-aa80b1cc776b&version=38","verifiedAt":"2026-07-22"},{"id":"fda-tirzepatide-2023","name":"U.S. Food and Drug Administration","sourceClass":"A","title":"FDA approves tirzepatide for chronic weight management","url":"https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management","verifiedAt":"2026-07-22"}],"subject":{"slug":"tirzepatide","type":"profile"}}